LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Planagumà, Jesús"
  2. AU="de Rezende, Grazielli Rocha"
  3. AU="Mohadeseh NEZAM"
  4. AU="Daniel Pecos-Martín"
  5. AU="Gentle, Popular"
  6. AU=Wang Jirui
  7. AU="Bielik, Martin"
  8. AU="Simon A.F. Darroch"
  9. AU="Suzuki, Kenichi G N"
  10. AU="Hu, Yizhong"
  11. AU=Sasaki Kotaro
  12. AU=Abd-Elsayed Alaa
  13. AU="Jung, Hee-Jun"
  14. AU="Struckmann, Stephan"
  15. AU=Coward Richard
  16. AU="Ghazizadeh, Shabnam"
  17. AU="Rebecca A Butcher"
  18. AU="Kimberlyn Roosa"
  19. AU=Chian Ri-Cheng
  20. AU="Alzalzalah, Sayed"
  21. AU=Kaufman Jonathan J
  22. AU="Kim, Jin K"
  23. AU="Zevakov, S A"
  24. AU="Sui Phang"
  25. AU="Kolomeichuk, Lilia V"
  26. AU="Sabuj Kanti Mistry"
  27. AU="Basurto-Lozada, Daniela"
  28. AU="Takashima, Shin-Ichiro"
  29. AU="Teresinha Leal"
  30. AU="Angélique B van 't Wout"
  31. AU="Roberts, Nicholas J"
  32. AU="Chauhan, Gaurav B"
  33. AU=Hanjaya-Putra Donny
  34. AU=Powell James
  35. AU="Russell, Todd"
  36. AU=Forth Scott
  37. AU="Kreutzer, Susanne" AU="Kreutzer, Susanne"
  38. AU="St John, Maie"
  39. AU=Gerhardy A
  40. AU="Qi, Huixin"
  41. AU="Dobosiewicz, May"
  42. AU="Srivastava, Rakesh"
  43. AU="Grevtsov K.I."

Suchergebnis

Treffer 1 - 10 von insgesamt 45

Suchoptionen

  1. Artikel ; Online: Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis.

    Cunquero, Marina / Aguilar, Esther / Loza-Alvarez, Pablo / Planagumà, Jesús

    Journal of visualized experiments : JoVE

    2022  , Heft 184

    Abstract: Over the last 15 years, a new category of antibody-mediated diseases of the central nervous system (CNS) has been characterized and is now defined as "autoimmune encephalitis" (AE). There are currently 17 known AE syndromes, and all are associated with ... ...

    Abstract Over the last 15 years, a new category of antibody-mediated diseases of the central nervous system (CNS) has been characterized and is now defined as "autoimmune encephalitis" (AE). There are currently 17 known AE syndromes, and all are associated with antibodies against the neuronal cell surface or synaptic proteins. The clinical syndromes are complex and vary according to the type of associated antibody. The best-known of these diseases is anti-N-methyl D-aspartate receptor (NMDAR) encephalitis, which is a prominent neuropsychiatric disorder associated with severe memory and behavioral impairments. The associated antibodies react with the GluN1 subunit of the NMDAR at the N-terminal domain. The approach most frequently used for the discovery and characterization of AE antibodies includes the culture of dissociated, fetal, rodent hippocampal neurons. During the process of antibody characterization, live neurons in culture are exposed to patients' serum or CSF, and the detection of reactivity indicates that the serum or CSF samples of the patient contain antibodies against neuronal surface antigens. Hippocampal cultures can also be used to determine whether the antibodies in patients are potentially pathogenic by examining if they cause structural or functional alterations of the neurons. The level of success of these studies depends on the quality of the cultures and on the protocols used to obtain and detect the reactivity of patient samples. This article provides an optimized protocol for primary cell culture of fetal rat hippocampal neurons combined with immunostaining to determine the presence of antibodies in the serum or CSF of patients. An example of how to examine the potential pathogenic effects of NMDAR antibodies using cultured neurons and calcium imaging is also presented.
    Mesh-Begriff(e) Animals ; Anti-N-Methyl-D-Aspartate Receptor Encephalitis/diagnosis ; Autoantibodies ; Encephalitis ; Hashimoto Disease ; Hippocampus/metabolism ; Humans ; Neurons/metabolism ; Rats ; Syndrome
    Chemische Substanzen Autoantibodies
    Sprache Englisch
    Erscheinungsdatum 2022-06-02
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Video-Audio Media ; Research Support, Non-U.S. Gov't
    ZDB-ID 2259946-0
    ISSN 1940-087X ; 1940-087X
    ISSN (online) 1940-087X
    ISSN 1940-087X
    DOI 10.3791/63829
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Autoimmune seizures and epilepsy.

    Geis, Christian / Planagumà, Jesus / Carreño, Mar / Graus, Francesc / Dalmau, Josep

    The Journal of clinical investigation

    2019  Band 129, Heft 3, Seite(n) 926–940

    Abstract: The rapid expansion in the number of encephalitis disorders associated with autoantibodies against neuronal proteins has led to an incremental increase in use of the term "autoimmune epilepsy," yet has occurred with limited attention to the ... ...

    Abstract The rapid expansion in the number of encephalitis disorders associated with autoantibodies against neuronal proteins has led to an incremental increase in use of the term "autoimmune epilepsy," yet has occurred with limited attention to the physiopathology of each disease and genuine propensity to develop epilepsy. Indeed, most autoimmune encephalitides present with seizures, but the probability of evolving to epilepsy is relatively small. The risk of epilepsy is higher for disorders in which the antigens are intracellular (often T cell-mediated) compared with disorders in which the antigens are on the cell surface (antibody-mediated). Most autoantibodies against neuronal surface antigens show robust effects on the target proteins, resulting in hyperexcitability and impairment of synaptic function and plasticity. Here, we trace the evolution of the concept of autoimmune epilepsy and examine common inflammatory pathways that might lead to epilepsy. Then, we focus on several antibody-mediated encephalitis disorders that associate with seizures and review the synaptic alterations caused by patients' antibodies, with emphasis on those that have been modeled in animals (e.g., antibodies against NMDA, AMPA receptors, LGI1 protein) or in cultured neurons (e.g., antibodies against the GABAb receptor).
    Mesh-Begriff(e) Animals ; Autoantibodies/immunology ; Autoantigens/immunology ; Autoimmune Diseases of the Nervous System/immunology ; Autoimmune Diseases of the Nervous System/pathology ; Disease Models, Animal ; Epilepsy/immunology ; Epilepsy/pathology ; Humans ; Immunity, Cellular ; Receptors, Antigen, T-Cell/immunology ; Synapses/immunology ; Synapses/pathology ; Synaptic Transmission/immunology ; T-Lymphocytes/immunology ; T-Lymphocytes/pathology
    Chemische Substanzen Autoantibodies ; Autoantigens ; Receptors, Antigen, T-Cell
    Sprache Englisch
    Erscheinungsdatum 2019-02-04
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 3067-3
    ISSN 1558-8238 ; 0021-9738
    ISSN (online) 1558-8238
    ISSN 0021-9738
    DOI 10.1172/JCI125178
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: NMDAR Antibodies Alter Dopamine Receptors and Cause Psychotic Behavior in Mice.

    Carceles-Cordon, Marc / Mannara, Francesco / Aguilar, Esther / Castellanos, Aida / Planagumà, Jesús / Dalmau, Josep

    Annals of neurology

    2020  Band 88, Heft 3, Seite(n) 603–613

    Abstract: Objective: The aim was to demonstrate that antibodies from patients with anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis alter the levels of dopamine 1 receptor (D1R) and dopamine 2 receptor (D2R) and cause psychotic-like features in mice.: ... ...

    Abstract Objective: The aim was to demonstrate that antibodies from patients with anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis alter the levels of dopamine 1 receptor (D1R) and dopamine 2 receptor (D2R) and cause psychotic-like features in mice.
    Methods: Cultured rat hippocampal neurons were treated with cerebrospinal fluid (CSF) from patients with anti-NMDAR encephalitis or controls, and the effects on clusters of D1R and D2R were quantified. In vivo studies included 71 C57BL/6J mice that were chronically infused with CSF from patients or controls through ventricular catheters connected to subcutaneous osmotic pumps. Prepulse inhibition of the acoustic startling reflex (PPI; a marker of psychotic-like behavior), memory, locomotor activity, and the density of cell-surface and synaptic D1R, D2R, and NMDAR clusters were examined at different time points using reported techniques.
    Results: In cultured neurons, CSF from patients, but not from controls, caused a significant decrease of cell-surface D1R and an increase of D2R clusters. In mice, CSF from patients caused a significant decrease of synaptic and total cell-surface D1R clusters and an increase of D2R clusters associated with a decrease of PPI. These effects were accompanied by memory impairment and a reduction of surface NMDARs, as reported in this model. The psychotic-like features, memory impairment, and changes in levels of D1R, D2R, and NMDAR progressively improved several days after the infusion of CSF from patients stopped.
    Interpretation: In addition to memory deficits and reduction of NMDARs, CSF antibodies from patients with anti-NMDAR encephalitis cause reversible psychotic-like features accompanied by changes (D1R decrease, D2R increase) in cell-surface dopamine receptor clusters. ANN NEUROL 2020 ANN NEUROL 2020;88:603-613.
    Mesh-Begriff(e) Adolescent ; Adult ; Animals ; Anti-N-Methyl-D-Aspartate Receptor Encephalitis/cerebrospinal fluid ; Anti-N-Methyl-D-Aspartate Receptor Encephalitis/immunology ; Anti-N-Methyl-D-Aspartate Receptor Encephalitis/metabolism ; Autoantibodies/cerebrospinal fluid ; Autoantibodies/pharmacology ; Female ; Humans ; Male ; Mice ; Mice, Inbred C57BL ; Neurons/drug effects ; Neurons/metabolism ; Psychotic Disorders ; Rats ; Rats, Wistar ; Receptors, Dopamine/drug effects ; Receptors, Dopamine/metabolism ; Reflex, Startle/drug effects ; Reflex, Startle/physiology ; Young Adult
    Chemische Substanzen Autoantibodies ; Receptors, Dopamine
    Sprache Englisch
    Erscheinungsdatum 2020-07-11
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 80362-5
    ISSN 1531-8249 ; 0364-5134
    ISSN (online) 1531-8249
    ISSN 0364-5134
    DOI 10.1002/ana.25829
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome.

    Sabater, Lidia / Planagumà, Jesús / Dalmau, Josep / Graus, Francesc

    Journal of neuroinflammation

    2016  Band 13, Heft 1, Seite(n) 226

    Abstract: Background: Antibodies against IgLON5, a neuronal adhesion protein of unknown function, are markers of a novel neurological disorder termed anti-IgLON5 syndrome. The disorder shows a remarkable association with the HLA-DQB1*0501 and HLA-DRB1*1001 ... ...

    Abstract Background: Antibodies against IgLON5, a neuronal adhesion protein of unknown function, are markers of a novel neurological disorder termed anti-IgLON5 syndrome. The disorder shows a remarkable association with the HLA-DQB1*0501 and HLA-DRB1*1001 alleles, and postmortem studies demonstrate a novel neuronal tauopathy predominantly involving the hypothalamus and tegmentum of the brainstem. The role of IgLON5 antibodies in the pathogenesis of the disease is currently unknown. Here, we have determined the target epitopes of IgLON5 antibodies, the effects of the IgLON5 antibodies in rat hippocampal neurons, and the IgG subclass responsible for these effects.
    Methods: HEK293 cells expressing several deletion constructs of IgLON5 were used to determine the epitopes recognized by the serum of 15 patients with anti-IgLON5 syndrome. The role of glycosylation in immunogenicity was tested with PNGase F treatment of transfected cells. Dissociated hippocampal neuronal cultures were used to test by immunocytochemistry the effects of total IgG, IgG1, and IgG4 subclasses of IgLON5 antibodies.
    Results: Patients' antibodies reacted with the immunoglobulin-like domain 2 of IgLON5. Glycosylation was not required for immunoreactivity. The predominant subclass of IgLON5 antibodies was IgG4 but all patients also had IgG1. The mean percentage of specific IgLON5 IgG4 and IgG1 of the samples analyzed by flow cytometry was 64 and 33 %, respectively. In cultures of hippocampal neurons, patients' antibodies caused a decrease of cell surface IgLON5 clusters that was not reversed after IgLON5 antibodies were removed from the media. The decrease of surface IgLON5 clusters correlated with the rate of antibody internalization. These effects were observed with purified IgG1 but not with the IgG4 antibodies.
    Conclusions: IgLON5 antibodies recognize the immunoglobulin-like domain 2 of the antigen, and the reactivity is not dependent on glycosylation. The effects observed on hippocampal neuronal cultures indicate an irreversible antibody-mediated internalization of surface IgLON5. These effects were mediated by specific IgLON5 IgG1 antibodies and suggest a pathogenic role of these antibodies in the disease.
    Mesh-Begriff(e) Animals ; Animals, Newborn ; Autoimmune Diseases/blood ; Autoimmune Diseases/immunology ; Autoimmune Diseases/pathology ; Cell Adhesion Molecules, Neuronal/genetics ; Cell Adhesion Molecules, Neuronal/immunology ; Cell Adhesion Molecules, Neuronal/metabolism ; Cells, Cultured ; Enzyme-Linked Immunosorbent Assay ; Glycosylation/drug effects ; HEK293 Cells ; HLA-DRB1 Chains ; Hippocampus/cytology ; Humans ; Immunodominant Epitopes/drug effects ; Immunodominant Epitopes/immunology ; Immunoglobulin Fab Fragments/metabolism ; Immunoglobulin G/chemistry ; Immunoglobulin G/classification ; Immunoglobulin G/metabolism ; Immunoglobulin G/pharmacology ; Mutation/genetics ; Neurons/drug effects ; Rats ; Time Factors ; Transfection
    Chemische Substanzen Cell Adhesion Molecules, Neuronal ; HLA-DRB1 Chains ; IgLON5 protein, human ; Immunodominant Epitopes ; Immunoglobulin Fab Fragments ; Immunoglobulin G
    Sprache Englisch
    Erscheinungsdatum 2016-09-01
    Erscheinungsland England
    Dokumenttyp Journal Article
    ISSN 1742-2094
    ISSN (online) 1742-2094
    DOI 10.1186/s12974-016-0689-1
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: Human Metabotropic Glutamate Receptor 5 Antibodies Alter Receptor Levels and Behavior in Mice.

    Maudes, Estibaliz / Mannara, Francesco / García-Serra, Anna / Radosevic, Marija / Mellado, Araceli / Serafim, Ana Beatriz / Planagumà, Jesús / Sabater, Lidia / Dalmau, Josep / Spatola, Marianna

    Annals of neurology

    2022  Band 92, Heft 1, Seite(n) 81–86

    Abstract: Ophelia syndrome or encephalitis with antibodies against the metabotropic glutamate receptor 5 (mGluR5) manifests with behavioral changes, memory deficits, and anxiety. To study the antibody pathogenicity, mice received continuous cerebroventricular ... ...

    Abstract Ophelia syndrome or encephalitis with antibodies against the metabotropic glutamate receptor 5 (mGluR5) manifests with behavioral changes, memory deficits, and anxiety. To study the antibody pathogenicity, mice received continuous cerebroventricular infusion of patients' or controls' immunoglobulin G (IgG) for 14 days, followed by a 15-day washout. The effects on hippocampal mGluR5 clusters were determined by confocal microscopy. Animals infused with patients' IgG, but not controls' IgG, showed memory impairment, increased anxiety, and decreased neuronal surface mGluR5 clusters. After antibody clearance, both behavioral and molecular changes reversed to baseline conditions. These findings support the pathogenicity of these antibodies in anti-mGluR5 encephalitis. ANN NEUROL 2022;92:81-86.
    Mesh-Begriff(e) Animals ; Autoantibodies ; Encephalitis ; Humans ; Immunoglobulin G ; Memory Disorders ; Mice ; Neurons ; Receptor, Metabotropic Glutamate 5
    Chemische Substanzen Autoantibodies ; Grm5 protein, mouse ; Immunoglobulin G ; Receptor, Metabotropic Glutamate 5 ; anti-mGluR5 autoantibody
    Sprache Englisch
    Erscheinungsdatum 2022-04-25
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 80362-5
    ISSN 1531-8249 ; 0364-5134
    ISSN (online) 1531-8249
    ISSN 0364-5134
    DOI 10.1002/ana.26362
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online: Allosteric Modulation of NMDARs Reverses Patients' Autoantibody Effects in Mice.

    Radosevic, Marija / Planagumà, Jesús / Mannara, Francesco / Mellado, Araceli / Aguilar, Esther / Sabater, Lidia / Landa, Jon / García-Serra, Anna / Maudes, Estibaliz / Gasull, Xavier / Lewis, Mike / Dalmau, Josep

    Neurology(R) neuroimmunology & neuroinflammation

    2021  Band 9, Heft 1

    Abstract: Background and objectives: To demonstrate that an analog (SGE-301) of a brain-derived cholesterol metabolite, 24(S)-hydroxycholesterol, which is a selective positive allosteric modulator (PAM) of NMDA receptors (NMDARs), is able to reverse the memory ... ...

    Abstract Background and objectives: To demonstrate that an analog (SGE-301) of a brain-derived cholesterol metabolite, 24(S)-hydroxycholesterol, which is a selective positive allosteric modulator (PAM) of NMDA receptors (NMDARs), is able to reverse the memory and synaptic alterations caused by CSF from patients with anti-NMDAR encephalitis in an animal model of passive transfer of antibodies.
    Methods: Four groups of mice received (days 1-14) patients' or controls' CSF via osmotic pumps connected to the cerebroventricular system and from day 11 were treated with daily subcutaneous injections of SGE-301 or vehicle (no drug). Visuospatial memory, locomotor activity (LA), synaptic NMDAR cluster density, hippocampal long-term potentiation (LTP), and paired-pulse facilitation (PPF) were assessed on days 10, 13, 18, and 26 using reported techniques.
    Results: On day 10, mice infused with patients' CSF, but not controls' CSF, presented a significant visuospatial memory deficit, reduction of NMDAR clusters, and impairment of LTP, whereas LA and PPF were unaffected. These alterations persisted until day 18, the time of maximal deficits in this model. In contrast, mice that received patients' CSF but from day 11 were treated with SGE-301 showed memory recovery (day 13), and on day 18, all paradigms (memory, NMDAR clusters, and LTP) had reversed to values similar to those of controls. On day 26, no differences were observed among experimental groups.
    Discussion: An oxysterol biology-based PAM of NMDARs is able to reverse the synaptic and memory deficits caused by CSF from patients with anti-NMDAR encephalitis. These findings suggest a novel adjuvant treatment approach that deserves future clinical evaluation.
    Mesh-Begriff(e) Animals ; Anti-N-Methyl-D-Aspartate Receptor Encephalitis/chemically induced ; Anti-N-Methyl-D-Aspartate Receptor Encephalitis/drug therapy ; Autoantibodies/administration & dosage ; Autoantibodies/cerebrospinal fluid ; Behavior, Animal/drug effects ; Cerebrospinal Fluid ; Disease Models, Animal ; Humans ; Hydroxycholesterols/analysis ; Hydroxycholesterols/pharmacology ; Male ; Memory Disorders/chemically induced ; Memory Disorders/drug therapy ; Mice ; Mice, Inbred C57BL
    Chemische Substanzen Autoantibodies ; Hydroxycholesterols ; 24-hydroxycholesterol (47IMW63S3F)
    Sprache Englisch
    Erscheinungsdatum 2021-12-13
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2767740-0
    ISSN 2332-7812 ; 2332-7812
    ISSN (online) 2332-7812
    ISSN 2332-7812
    DOI 10.1212/NXI.0000000000001122
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: Blocking Placental Class G Immunoglobulin Transfer Prevents NMDA Receptor Antibody Effects in Newborn Mice.

    García-Serra, Anna / Radosevic, Marija / Ríos, José / Aguilar, Esther / Maudes, Estibaliz / Landa, Jon / Sabater, Lidia / Martinez-Hernandez, Eugenia / Planagumà, Jesús / Dalmau, Josep

    Neurology(R) neuroimmunology & neuroinflammation

    2021  Band 8, Heft 6

    Abstract: Background and objectives: To determine in a mouse model whether neonatal Fc receptor (FcRn) blockade prevents the placental transfer of class G immunoglobulin (IgG) derived from patients with anti-NMDA receptor (NMDAR) encephalitis and their pathogenic ...

    Abstract Background and objectives: To determine in a mouse model whether neonatal Fc receptor (FcRn) blockade prevents the placental transfer of class G immunoglobulin (IgG) derived from patients with anti-NMDA receptor (NMDAR) encephalitis and their pathogenic effects on the fetuses and offspring.
    Methods: Pregnant C57BL/6J mice were administered via tail vein FcRn antibody (FcRn-ab) or saline solution 6 hours before administration of patients' or controls' IgG on days 14, 15, and 16 of gestation. Three experimental groups were established: mice receiving controls' IgG, patients' IgG, or patients' IgG along with pretreatment with FcRn-ab. Immunohistochemical staining, confocal microscopy, hippocampal long-term potentiation, and standardized developmental and behavioral tasks were used to assess the efficacy of treatment with FcRn-ab.
    Results: In pregnant mice that received patients' IgG, treatment with FcRn-ab prevented the IgG from reaching the fetal brain, abrogating the decrease of NMDAR clusters and the reduction of cortical plate thickness that were observed in fetuses from untreated pregnant mice. Moreover, among the offspring of mothers that received patients' IgG, those whose mothers were treated with FcRn-ab did not develop the alterations that occurred in offspring of untreated mothers, including impairment in hippocampal plasticity, delay in innate reflexes, and visuospatial memory deficits.
    Discussion: FcRn blockade prevents placental transfer of IgG from patients with anti-NMDAR encephalitis and abrogates the synaptic and neurodevelopmental alterations caused by patients' antibodies. This model has potential therapeutic implications for other antibody-mediated diseases of the CNS during pregnancy.
    Mesh-Begriff(e) Animals ; Animals, Newborn ; Anti-N-Methyl-D-Aspartate Receptor Encephalitis/immunology ; Antibodies, Blocking/administration & dosage ; Autoantibodies/administration & dosage ; Disease Models, Animal ; Female ; Histocompatibility Antigens Class I/immunology ; Humans ; Immunoglobulin G/administration & dosage ; Maternal-Fetal Exchange/drug effects ; Mice ; Mice, Inbred C57BL ; Placental Circulation/drug effects ; Pregnancy ; Receptors, Fc/immunology
    Chemische Substanzen Antibodies, Blocking ; Autoantibodies ; Histocompatibility Antigens Class I ; Immunoglobulin G ; Receptors, Fc ; Fc receptor, neonatal (TW3XAW0RCY)
    Sprache Englisch
    Erscheinungsdatum 2021-09-27
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2767740-0
    ISSN 2332-7812 ; 2332-7812
    ISSN (online) 2332-7812
    ISSN 2332-7812
    DOI 10.1212/NXI.0000000000001061
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  8. Artikel ; Online: Human CASPR2 Antibodies Reversibly Alter Memory and the CASPR2 Protein Complex.

    Joubert, Bastien / Petit-Pedrol, Mar / Planagumà, Jesús / Mannara, Francesco / Radosevic, Marija / Marsal, Maria / Maudes, Estibaliz / García-Serra, Anna / Aguilar, Esther / Andrés-Bilbé, Alba / Gasull, Xavier / Loza-Alvarez, Pablo / Sabater, Lidia / Rosenfeld, Myrna R / Dalmau, Josep

    Annals of neurology

    2022  Band 91, Heft 6, Seite(n) 801–813

    Abstract: Objective: The encephalitis associated with antibodies against contactin-associated proteinlike 2 (CASPR2) is presumably antibody-mediated, but the antibody effects and whether they cause behavioral alterations are not well known. Here, we used a mouse ... ...

    Abstract Objective: The encephalitis associated with antibodies against contactin-associated proteinlike 2 (CASPR2) is presumably antibody-mediated, but the antibody effects and whether they cause behavioral alterations are not well known. Here, we used a mouse model of patients' immunoglobulin G (IgG) transfer and super-resolution microscopy to demonstrate the antibody pathogenicity.
    Methods: IgG from patients with anti-CASPR2 encephalitis or healthy controls was infused into the cerebroventricular system of mice. The levels and colocalization of CASPR2 with transient axonal glycoprotein 1 (TAG1) were determined with stimulated emission depletion microscopy (40-70μm lateral resolution). Hippocampal clusters of Kv1.1 voltage-gated potassium channels (VGKCs) and GluA1-containing α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) were quantified with confocal microscopy. Behavioral alterations were assessed with standard behavioral paradigms. Cultured neurons were used to determine the levels of intracellular CASPR2 and TAG1 after exposure to patients' IgG.
    Results: Infusion of patients' IgG, but not controls' IgG, caused memory impairment along with hippocampal reduction of surface CASPR2 clusters and decreased CASPR2/TAG1 colocalization. In cultured neurons, patients' IgG led to an increase of intracellular CASPR2 without affecting TAG1, suggesting selective CASPR2 internalization. Additionally, mice infused with patients' IgG showed decreased levels of Kv1.1 and GluA1 (two CASPR2-regulated proteins). All these alterations and the memory deficit reverted to normal after removing patients' IgG.
    Interpretation: IgG from patients with anti-CASPR2 encephalitis causes reversible memory impairment, inhibits the interaction of CASPR2/TAG1, and decreases the levels of CASPR2 and related proteins (VGKC, AMPAR). These findings fulfill the postulates of antibody-mediated disease and provide a biological basis for antibody-removing treatment approaches. ANN NEUROL 2022;91:801-813.
    Mesh-Begriff(e) Animals ; Autoantibodies/immunology ; Contactin 2/immunology ; Encephalitis/immunology ; Humans ; Immunoglobulin G/metabolism ; Membrane Proteins/immunology ; Membrane Proteins/metabolism ; Mice ; Nerve Tissue Proteins/immunology ; Nerve Tissue Proteins/metabolism ; Potassium Channels, Voltage-Gated
    Chemische Substanzen Autoantibodies ; CNTNAP2 protein, human ; CNTNAP2 protein, mouse ; Contactin 2 ; Immunoglobulin G ; Membrane Proteins ; Nerve Tissue Proteins ; Potassium Channels, Voltage-Gated ; anti-CASPR2 autoantibody
    Sprache Englisch
    Erscheinungsdatum 2022-03-22
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 80362-5
    ISSN 1531-8249 ; 0364-5134
    ISSN (online) 1531-8249
    ISSN 0364-5134
    DOI 10.1002/ana.26345
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Artikel: Mouse model of anti-NMDA receptor post-herpes simplex encephalitis.

    Linnoila, Jenny / Pulli, Benjamin / Armangué, Thaís / Planagumà, Jesús / Narsimhan, Radha / Schob, Stefan / Zeller, Matthias W G / Dalmau, Josep / Chen, John

    Neurology(R) neuroimmunology & neuroinflammation

    2018  Band 6, Heft 2, Seite(n) e529

    Abstract: Objective: To develop an endogenous rodent model of postinfectious anti-NMDA receptor (NMDAR) encephalitis.: Methods: Six mice were inoculated intranasally with herpes simplex virus (HSV) 1 and subsequently treated with acyclovir for 2 weeks. Serum ... ...

    Abstract Objective: To develop an endogenous rodent model of postinfectious anti-NMDA receptor (NMDAR) encephalitis.
    Methods: Six mice were inoculated intranasally with herpes simplex virus (HSV) 1 and subsequently treated with acyclovir for 2 weeks. Serum was collected at 3, 6, and 8 weeks postinoculation and tested for NMDAR antibodies through a cell-based assay. Eight weeks postinoculation, mice were killed and their brains were sectioned and immunostained with antibodies to postsynaptic density (PSD)-95 and NMDARs. Colocalization of hippocampal PSD-95 and NMDAR clusters, representing postsynaptic membrane NMDARs, was quantified via confocal imaging. Hippocampi were additionally analyzed for NMDAR and PSD-95 protein using Western blot analysis.
    Results: Four of 6 mice (67%) developed serum antibodies to NMDARs: 1 at 3 weeks, 1 at 6 weeks, and 2 at 8 weeks postinoculation. As compared to inoculated mice that did not develop NMDAR antibodies, immunofluorescence staining revealed decreased hippocampal postsynaptic membrane NMDARs in mice with serum antibodies at 8 weeks postinoculation. Western blot analysis showed that mice that had NMDAR antibodies at 8 weeks had decreased total NMDAR but not PSD-95 protein in hippocampal extracts (
    Conclusions: Mice inoculated intranasally with HSV-1 developed serum NMDAR antibodies. These antibodies were associated with reduced hippocampal NMDARs, as has been shown in previous models where antibodies from patients with anti-NMDAR encephalitis were infused into mice, paving the way for future studies into the pathophysiology of autoimmune encephalitides.
    Mesh-Begriff(e) Acyclovir/administration & dosage ; Animals ; Anti-N-Methyl-D-Aspartate Receptor Encephalitis/virology ; Antibodies/blood ; Disease Models, Animal ; Disks Large Homolog 4 Protein/metabolism ; Encephalitis, Herpes Simplex/virology ; Female ; Herpesvirus 1, Human/physiology ; Hippocampus/metabolism ; Hippocampus/virology ; Mice, Inbred BALB C ; Receptors, N-Methyl-D-Aspartate/immunology ; Receptors, N-Methyl-D-Aspartate/metabolism
    Chemische Substanzen Antibodies ; Disks Large Homolog 4 Protein ; Dlg4 protein, mouse ; Receptors, N-Methyl-D-Aspartate ; Acyclovir (X4HES1O11F)
    Sprache Englisch
    Erscheinungsdatum 2018-12-26
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2767740-0
    ISSN 2332-7812
    ISSN 2332-7812
    DOI 10.1212/NXI.0000000000000529
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Artikel ; Online: Pregnancy outcomes in anti-NMDA receptor encephalitis: Case series.

    Joubert, Bastien / García-Serra, Anna / Planagumà, Jesús / Martínez-Hernandez, Eugenia / Kraft, Andrea / Palm, Frederick / Iizuka, Takahiro / Honnorat, Jérôme / Leypoldt, Frank / Graus, Francesc / Dalmau, Josep

    Neurology(R) neuroimmunology & neuroinflammation

    2020  Band 7, Heft 3

    Abstract: Objective: To report the effects of anti-NMDA receptor (NMDAR) encephalitis in pregnant patients and their babies.: Methods: We studied a retrospective cohort of patients who developed anti-NMDAR encephalitis during pregnancy or became pregnant while ...

    Abstract Objective: To report the effects of anti-NMDA receptor (NMDAR) encephalitis in pregnant patients and their babies.
    Methods: We studied a retrospective cohort of patients who developed anti-NMDAR encephalitis during pregnancy or became pregnant while recovering from the encephalitis. In addition, we reviewed the English literature between 2010 and 2019 related to this topic.
    Results: We studied 11 patients; 6 developed anti-NMDAR encephalitis during pregnancy, and 5 became pregnant while recovering. There were no obstetrical complications, but 6 (55%) babies were premature. Ten newborns were healthy, and 1 (9%) developed transient respiratory distress. Nine infants had assessable follow-up (median 18 months; range, 7-96 months), and all showed normal development. We identified 21 cases in the English literature. Obstetrical complications occurred in 7 (33%) pregnancies. Two patients died of septic shock (1 baby successfully delivered), another 2 had miscarriages, and in 2, the pregnancy was terminated. Sixteen babies (76%) were delivered, 9 (56%) premature. At birth, 13/16 (81%) newborns were healthy, 2/16 (13%) had transient neurologic or respiratory symptoms, and 1 (6%) died of brain edema. Follow-up (median 12 months; range, 6-36 months) was reported for 8 children: 7 (88%) showed normal development and behavior, and 1 (13%) cortical dysplasia. Immunotherapy was used during pregnancy in 7 (64%) of our patients and 18 (86%) of the reported cases, including rituximab in 4 cases, without adverse effects.
    Conclusions: Patients who develop anti-NMDAR encephalitis during pregnancy or become pregnant during recovery often have obstetrical complications, but most of the newborns are healthy and appear to have normal development.
    Mesh-Begriff(e) Adolescent ; Adult ; Anti-N-Methyl-D-Aspartate Receptor Encephalitis/blood ; Anti-N-Methyl-D-Aspartate Receptor Encephalitis/cerebrospinal fluid ; Anti-N-Methyl-D-Aspartate Receptor Encephalitis/epidemiology ; Anti-N-Methyl-D-Aspartate Receptor Encephalitis/immunology ; Female ; Humans ; Infant, Newborn ; Obstetric Labor Complications/epidemiology ; Pregnancy ; Pregnancy Complications/blood ; Pregnancy Complications/cerebrospinal fluid ; Pregnancy Complications/epidemiology ; Pregnancy Complications/immunology ; Pregnancy Outcome/epidemiology ; Retrospective Studies ; Young Adult
    Sprache Englisch
    Erscheinungsdatum 2020-01-16
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2767740-0
    ISSN 2332-7812 ; 2332-7812
    ISSN (online) 2332-7812
    ISSN 2332-7812
    DOI 10.1212/NXI.0000000000000668
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang